Skip to main content
SpringerLink
Log in

Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

The prevalence of polycystic ovary syndrome (PCOS) and its distinct clinical phenotypes were assessed using 3 sets of international diagnostic criteria in women self-reporting concerns over outward features of PCOS. Revised ultrasonographic criteria for polycystic ovaries (PCO) based on modern ultrasound technology were used. Of the participants, 53%, 62%, and 70% were diagnosed with PCOS using National Institutes of Health, Androgen Excess and PCOS Society, and Rotterdam criteria, respectively. Prevalence of Frank, Ovulatory, Normoandrogenic, and Non-PCO PCOS were 66%, 13%, 11%, and 9%, respectively. Frank PCOS was associated with the severest metabolic disturbances whereas metabolic profiles in Normoandrogenic PCOS did not differ from controls, supporting reduced health risks in women without androgen excess. Metabolic disturbances and hyperandrogenism were linked to excess adiposity across all the groups. Using updated criteria for PCO, the prevalence of Non-PCO PCOS and PCO alone in healthy women recruited from the general population was reduced compared to the previous reports.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181–191.

    Article  Google Scholar 

  2. Azziz R. Diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006; 91(3):781–785.

    Article  CAS  PubMed  Google Scholar 

  3. Lujan M, Chizen D, Pierson R. Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J Obstet Gynecol Canada. 2008;30(8):671–679.

    Article  Google Scholar 

  4. Zawadzki JK, Dunaif A. Diagnostic Criteria for Polycystic Ovary Syndrome: Towards a Rational Approach. Boston: Blackwell Scientific Publications; 1992.

    Google Scholar 

  5. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril. 2004;81(1):19–25.

    Article  Google Scholar 

  6. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47.

    Article  Google Scholar 

  7. Azziz R, Carmina E, Dewailly D, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline. J Clin Endocrinol Metab. 2006;91(11):4237–4245.

    Article  CAS  PubMed  Google Scholar 

  8. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370(9588):685–697.

    Article  CAS  PubMed  Google Scholar 

  9. Moghetti P, Tosi F, Bonin C, et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98(4):E628–E637.

    Article  CAS  PubMed  Google Scholar 

  10. Guastella E, Longo RA, Carmina E. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril. 2010;94(6):2197–2201.

    Article  CAS  PubMed  Google Scholar 

  11. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol. 1983;61(4): 403–407.

    CAS  PubMed  Google Scholar 

  12. Johnstone EB, Rosen MP, Neril R, et al. The polycystic ovary post-rotterdam: A common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab. 2010;95(11):4965–4972.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lujan ME, Jarrett BY, Brooks ED, et al. Updated ultrasound criteria for polycystic ovary syndrome: Reliable thresholds for elevated follicle population and ovarian volume. Hum Reprod. 2013;28(5):1361–1368.

    Article  PubMed  Google Scholar 

  14. Dewailly D, Gronier H, Poncelet E, et al. Diagnosis of polycystic ovary syndrome (PCOS): Revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011;26(11): 3123–3129.

    Article  CAS  PubMed  Google Scholar 

  15. Allemand MC, Tummon IS, Phy JL, Foong SC, Dumesic DA, Session DR. Diagnosis of polycystic ovaries by three-dimensional transvaginal ultrasound. Fertil Steril. 2006;85(1):214–219.

    Article  PubMed  Google Scholar 

  16. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21(11):1440–1447.

    Article  CAS  PubMed  Google Scholar 

  17. Fraser IS, Critchley HOD, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? Hum Reprod. 2007;22(3):635–643.

    Article  PubMed  Google Scholar 

  18. Lujan ME, Brooks ED, Kepley AL, Chizen DR, Pierson RA, Peppin AK. Grid analysis improves reliability in follicle counts made by ultrasonography in women with polycystic ovary syndrome. Ultrasound Med Biol. 2010;36(5):712–718.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lujan M, Bloski TG, Chizen DR, Lehotay DC, Pierson RA. Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome. Hum Reprod. 2010;25(1):204–211.

    Article  CAS  PubMed  Google Scholar 

  20. Legro RS, Schlaff WD, Diamond MP, et al. Total testosterone assays in women with polycystic ovary syndrome: Precision and correlation with hirsutism. J Clin Endocrinol Metab. 2010;95(12): 5305–5313.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of polycystic ovary syndrome. Clin Endocrinol. 2008;69(1):52–60.

    Article  CAS  Google Scholar 

  22. Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067–3073.

    Article  PubMed  Google Scholar 

  23. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544–551.

    Article  PubMed  Google Scholar 

  24. Pehlivanov B, Orbetzova M. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecol Endocrinol. 2007;23(10):604–609.

    Article  CAS  PubMed  Google Scholar 

  25. Diamanti-Kandarakis E, Panidis D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol. 2007; 67(5):735–742.

    Article  CAS  Google Scholar 

  26. Guo M, Chen ZJ, Macklon NS, et al. Cardiovascular and metabolic characteristics of infertile chinese women with PCOS diagnosed according to the rotterdam consensus criteria. Reprod Biomed Online. 2010;21(4):572–580.

    Article  CAS  PubMed  Google Scholar 

  27. Ma YM, Li R, Qiao J, Zhang XW, et al. Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations. Chin Med J (Engl). 2010;123(16): 2185–2189.

    Google Scholar 

  28. Yilmaz M, Isaoglu U, Delibas IB, Kadanali S. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. J Obstet Gynaecol Res. 2011;37(8):1020–1026.

    Article  PubMed  Google Scholar 

  29. Wijeyaratne CN, Seneviratne Rde A, Dahanayake S, et al. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist endocrine clinic. Hum Reprod. 2011;26(1): 202–213.

    Article  CAS  PubMed  Google Scholar 

  30. Panidis D, Tziomalos K, Misichronis G, et al. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod. 2012; 27(2):541–549.

    Article  CAS  PubMed  Google Scholar 

  31. Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Sancho J, San Millan JL. Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women. Diabetologia. 2003;46(5): 625–633.

    Article  CAS  PubMed  Google Scholar 

  32. Panidis D, Tziomalos K, Papadakis E, et al. The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome. Eur J Endocrinol. 2013; 168(6):871–877.

    Article  CAS  PubMed  Google Scholar 

  33. Nybacka A, Carlstrom K, Stahle A, Nyren S, Hellstrom PM, Hirschberg AL. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome. Fertil Steril. 2011;96(6):1508–1513.

    Article  PubMed  Google Scholar 

  34. Ucak S, Basat O, Satir E, Altunas Y. Evaluation of various insulin sensitivity indices in lean idiopathic hirsutism patients. Endocr J. 2012;59(4):291–296.

    Article  CAS  PubMed  Google Scholar 

  35. Catteau-Jonard S, Bancquart J, Poncelet E, Lefebvre-Maunoury C, Robin G, Dewailly D. Polycystic ovaries at ultrasound: Normal variant or silent polycystic ovary syndrome? Ultrasound Obstet Gynecol. 2012;40(2):223–229.

    Article  CAS  PubMed  Google Scholar 

  36. Chang PL, Lindheim SR, Lowre C, et al. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab. 2000;85(3):995–1000.

    CAS  PubMed  Google Scholar 

  37. Carmina E, Wong L, Chang L, et al. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. Hum Reprod. 1997;12(5):905–909.

    Article  CAS  PubMed  Google Scholar 

  38. Adams JM, Taylor AE, Crowley WF, Hall JE. Polycystic ovarian morphology with regular ovulatory cycles: Insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab. 2004;89(9):4343.

    Article  CAS  PubMed  Google Scholar 

  39. Norman RJ, Hague WM, Masters SC, Wang XJ. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod. 1995;10(9):2258–2261.

    Article  CAS  PubMed  Google Scholar 

  40. Cenk Sayin N, Gücer F, Balkanli-Kaplan P, Ali Yüce M, Yardim T. Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome. Gynecol Endocrinol. 2003;17(5): 387–396.

    Article  CAS  PubMed  Google Scholar 

  41. Wang S, Alvero R. Racial and ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome. Semin Reprod Med. 2013;31(5):365–369.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nutritional Sciences, Human Metabolic Research Unit, Cornell University, 216 Savage Hall, 14853, Ithaca, NY, USA

    Nina M. Clark BS, Amanda J. Podolski BA, Eric D. Brooks BS & Marla E. Lujan PhD

  2. Department of Obstetrics, Gynecology & Reproductive Sciences, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

    Donna R. Chizen MD & Roger A. Pierson PhD

  3. Department of Pathology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

    Denis C. Lehotay PhD

Authors
  1. Nina M. Clark BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amanda J. Podolski BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric D. Brooks BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Donna R. Chizen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roger A. Pierson PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Denis C. Lehotay PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marla E. Lujan PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marla E. Lujan PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Clark, N.M., Podolski, A.J., Brooks, E.D. et al. Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome. Reprod. Sci. 21, 1034–1043 (2014). https://doi.org/10.1177/1933719114522525

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719114522525

Keywords

Search

Navigation